Lexicon Pharmaceuticals, Inc. (LXRX)
NASDAQ·Healthcare·Biotechnology
$1.89
+6.18%
Mkt Cap $716.38M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$6.00
Range $6.00 – $6.00
Implied Upside
+218.3%
Consensus $6.00 vs current $1.89
NASDAQ·Healthcare·Biotechnology
$1.89
+6.18%
Mkt Cap $716.38M
No recent rating data.
Price Target (2 analysts)
$6.00
Range $6.00 – $6.00
+218.3%
Consensus $6.00 vs current $1.89